Publication: COVID-19 Versus Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and ATP
Loading...
Date
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Abraham, Edward, Guido Guidotti, Eliezer Rapaport, David Bower, Jack Brown, et al. 2020. "COVID-19 Versus Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and ATP." Pre-print.
Abstract
We previously published an article in Science discussing the role of ATP in cystic fibrosis (CF). (1) In this manuscript, we update the findings published in that article and add new evidence that the elevated levels of ATP in CF patients may have a protective benefit CF patients infected by SARS-CoV-2 and suffereing from COVID-19. By extension, we suggest a therapeutic regimen that may benefit COVID-19 in the general populaton.
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service